Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Wisconsin, Madison |
---|---|
Information provided by: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00692120 |
Vitamin D is available in two forms, vitamin D2 and vitamin D3. It has previously been assumed that these two forms maintain blood vitamin D equally. However, this may not be the case. This study will evaluate whether D2 and D3 produce equal elevation of blood vitamin D. Additionally, it will evaluate whether once per month vitamin D dosing is as effective in maintaining blood vitamin D levels as daily dosing.
Condition | Intervention |
---|---|
Vitamin D Inadequacy Vitamin D Deficiency |
Dietary Supplement: Cholecalciferol (vitamin D3) Dietary Supplement: Ergocalciferol (vitamin D2) Dietary Supplement: Placebo |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment, Safety/Efficacy Study |
Official Title: | Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy |
Enrollment: | 64 |
Study Start Date: | February 2007 |
Estimated Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Dietary Supplement: Ergocalciferol (vitamin D2)
oral capsule 50,000 IU once monthly for 12 months
Dietary Supplement: Placebo
oral placebo capsule once daily for 12 months
|
2: Experimental |
Dietary Supplement: Ergocalciferol (vitamin D2)
oral capsule 1600 IU once daily for 12 months
Dietary Supplement: Placebo
oral placebo capsule once daily for 12 months
|
3: Experimental |
Dietary Supplement: Cholecalciferol (vitamin D3)
50,000 IU once monthly for 12 months
Dietary Supplement: Placebo
oral placebo capsule once daily for 12 months
|
4: Experimental |
Dietary Supplement: Cholecalciferol (vitamin D3)
oral capsule 1600 IU once daily for 12 months
Dietary Supplement: Placebo
oral placebo capsule once daily for 12 months
|
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Wisconsin | |
UW Osteoporosis Clinical and Research Program | |
Madison, Wisconsin, United States, 53705 |
Principal Investigator: | Neil Binkley, MD | University of Wisconsin - Institute on Aging |
Responsible Party: | University of Wisconsin - Institute on Aging ( Neil Binkley, MD ) |
Study ID Numbers: | 2006-0013 |
Study First Received: | January 2, 2008 |
Last Updated: | June 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00692120 |
Health Authority: | United States: Institutional Review Board |
Vitamin D Deficiency Cholecalciferol Vitamin D Malnutrition |
Avitaminosis Ergocalciferols Nutrition Disorders Deficiency Diseases |
Growth Substances Vitamins Physiological Effects of Drugs |
Bone Density Conservation Agents Micronutrients Pharmacologic Actions |